|
1
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song T, Yang H, Ho JC, Tang SC, Sze SC,
Lao L, Wang Y and Zhang KY: Expression of aquaporin 5 in primary
carcinoma and lymph node metastatic carcinoma of non-small cell
lung cancer. Oncol Lett. 9:2799–2804. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ge XJ, Zheng LM, Feng ZX, Li MY, Liu L,
Zhao YJ and Jiang JY: H19 contributes to poor clinical features in
NSCLC patients and leads to enhanced invasion in A549 cells through
regulating miRNA-203-mediated epithelial-mesenchymal transition.
Oncol Lett. 16:4480–4488. 2018.PubMed/NCBI
|
|
5
|
O'Flaherty JD, Gray S, Richard D, Fennell
D, O'Leary JJ, Blackhall FH and O'Byrne KJ: Circulating tumour
cells, their role in metastasis and their clinical utility in lung
cancer. Lung Cancer. 76:19–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim
Biophys Acta. 1856:189–210. 2015.PubMed/NCBI
|
|
7
|
Sholl LM, Aisner DL, Varella-Garcia M,
Berry LD, Dias-Santagata D, Wistuba II, Chen H, Fujimoto J, Kugler
K, Franklin WA, et al: Multi-institutional oncogenic driver
mutation analysis in lung adenocarcinoma: The lung cancer mutation
consortium experience. J Thorac Oncol. 10:768–777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishimoto S, Wada K, Usami Y, Tanaka N,
Aikawa T, Okura M, Nakajima A, Kogo M and Kamisaki Y: Differential
expression of aquaporin 5 and aquaporin 3 in squamous cell
carcinoma and adenoid cystic carcinoma. Int J Oncol. 41:67–75.
2012.PubMed/NCBI
|
|
9
|
Moon C, Soria JC, Jang SJ, Lee J, Obaidul
Hoque M, Sibony M, Trink B, Chang YS, Sidransky D and Mao L:
Involvement of aquaporins in colorectal carcinogenesis. Oncogene.
22:6699–6703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chae YK, Woo J, Kim MJ, Kang SK, Kim MS,
Lee J, Lee SK, Gong G, Kim YH, Soria JC, et al: Expression of
aquaporin 5 (AQP5) promotes tumor invasion in human non small cell
lung cancer. PLoS One. 3:e21622008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Machida Y, Ueda Y, Shimasaki M, Sato K,
Sagawa M, Katsuda S and Sakuma T: Relationship of aquaporin 1, 3,
and 5 expression in lung cancer cells to cellular differentiation,
invasive growth, and metastasis potential. Hum Pathol. 42:669–678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mobasheri A, Airley R, Hewitt SM and
Marples D: Heterogeneous expression of the aquaporin 1 (AQP1) water
channel in tumors of the prostate, breast, ovary, colon and lung: A
study using high density multiple human tumor tissue microarrays.
Int J Oncol. 26:1149–1158. 2005.PubMed/NCBI
|
|
13
|
Woo J, Lee J, Chae YK, Kim MS, Baek JH,
Park JC, Park MJ, Smith IM, Trink B, Ratovitski E, et al:
Overexpression of AQP5, a putative oncogene, promotes cell growth
and transformation. Cancer Lett. 264:54–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jo YM, Park TI, Lee HY, Jeong JY and Lee
WK: Prognostic significance of aquaporin 5 expression in non-small
cell lung cancer. J Pathol Transl Med. 50:122–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papadopoulos MC and Saadoun S: Key roles
of aquaporins in tumor biology. Biochim Biophys Acta.
1848:2576–2583. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu S, Zhang S, Jiang H, Yang Y and Jiang
Y: Co-expression of AQP3 and AQP5 in esophageal squamous cell
carcinoma correlates with aggressive tumor progression and poor
prognosis. Med Oncol. 30:6362013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JY and Juhnn YS: cAMP signaling
increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt
pathway in H1299 lung cancer cells. Exp Mol Med. 49:e2972017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang A, Zhao C, Liu X, Su W, Duan G, Xie
Z, Chu S and Gao Y: Knockdown of TBRG4 affects tumorigenesis in
human H1299 lung cancer cells by regulating DDIT3, CAV1 and RRM2.
Oncol Lett. 15:121–128. 2018.PubMed/NCBI
|
|
19
|
Zhang Z, Chen Z, Song Y, Zhang P, Hu J and
Bai C: Expression of aquaporin 5 increases proliferation and
metastasis potential of lung cancer. J Pathol. 221:210–220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wee P and Wang Z: Epidermal growth factor
receptor cell proliferation signaling pathways. Cancers (Basel).
9:E522017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nico B and Ribatti D: Aquaporins in tumor
growth and angiogenesis. Cancer Lett. 294:135–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun X, Wei J, Tang Y, Wang B, Zhang Y, Shi
L, Guo J, Hu F and Li X: Leptin-induced migration and angiogenesis
in rheumatoid arthritis is mediated by reactive oxygen species.
FEBS Open Bio. 7:1899–1908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo X, Sun T, Yang M, Li Z, Li Z and Gao
Y: Prognostic value of combined aquaporin 3 and aquaporin 5
overexpression in hepatocellular carcinoma. Biomed Res Int.
2013:2065252013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watanabe T, Fujii T, Oya T, Horikawa N,
Tabuchi Y, Takahashi Y, Morii M, Takeguchi N, Tsukada K and Sakai
H: Involvement of aquaporin-5 in differentiation of human gastric
cancer cells. J Physiol Sci. 59:113–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee SJ, Chae YS, Kim JG, Kim WW, Jung JH,
Park HY, Jeong JY, Park JY, Jung HJ and Kwon TH: AQP5 expression
predicts survival in patients with early breast cancer. Ann Surg
Oncol. 21:375–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia H, Ma YF, Yu CH, Li YJ, Tang J, Li JB,
Zhao YN and Liu Y: Aquaporin 3 knockdown suppresses tumour growth
and angiogenesis in experimental non-small cell lung cancer. Exp
Physiol. 99:974–984. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang T, Zhao C, Chen D and Zhou Z:
Overexpression of AQP5 in cervical cancer: Correlation with
clinicopathological features and prognosis. Med Oncol.
29:1998–2004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu YL, Matsuzaki T, Nakazawa T, Murata S,
Nakamura N, Kondo T, Iwashina M, Mochizuki K, Yamane T, Takata K
and Katoh R: Expression of aquaporin 3 (AQP3) in normal and
neoplastic lung tissues. Hum Pathol. 38:171–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mobasheri A and Marples D: Expression of
the AQP-1 water channel in normal human tissues: A semiquantitative
study using tissue microarray technology. Am J Physiol Cell
Physiol. 286:C529–C537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Funaki H, Yamamoto T, Koyama Y, Kondo D,
Yaoita E, Kawasaki K, Kobayashi H, Sawaguchi S, Abe H and Kihara I:
Localization and expression of AQP5 in cornea, serous salivary
glands, and pulmonary epithelial cells. Am J Physiol.
275:C1151–C1157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jung HJ, Park JY, Jeon HS and Kwon TH:
Aquaporin-5: A marker protein for proliferation and migration of
human breast cancer cells. PLoS One. 6:e284922011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawedia JD, Yang F, Sartor MA, Gozal D,
Czyzyk-Krzeska M and Menon AG: Hypoxia and hypoxia mimetics
decrease aquaporin 5 (AQP5) expression through both hypoxia
inducible factor-1α and proteasome-mediated pathways. PLoS One.
8:e575412013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Verkman MS: Role of aquaporin water
channels in kidney and lung. Am J Med Sci. 316:310–320. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang W, Li Q, Yang T, Li D, Ding F, Sun H
and Bai G: RNA interference-mediated silencing of aquaporin (AQP)-5
hinders angiogenesis of colorectal tumor by suppressing the
production of vascular endothelial growth factor. Neoplasma.
65:55–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
